Literature DB >> 27695872

Understanding cardiomyocyte proliferation: an insight into cell cycle activity.

Murugavel Ponnusamy1, Pei-Feng Li2, Kun Wang3.   

Abstract

Cardiomyocyte proliferation and regeneration are key to the functional recovery of myocardial tissue from injury. In the recent years, studies on cardiomyocyte proliferation overturned the traditional belief that adult cardiomyocytes permanently withdraw from the cell cycle activity. Hence, targeting cardiomyocyte proliferation is one of the potential therapeutic strategies for myocardial regeneration and repair. To achieve this, a deep understanding of the fundamental mechanisms involved in cardiomyocyte cell cycle as well as differences between neonatal and adult cardiomyocytes' cell cycle activity is required. This review focuses on the recent progress in understanding of cardiomyocyte cell cycle activity at different life stages viz., gestation, birth, and adulthood. The temporal expression/activities of major cell cycle activators (cyclins and CDKs), inhibitors (p21, p27, p57, p16, and p18), and cell-cycle-associated proteins (Rb, p107, and p130) in cardiomyocytes during gestation and postnatal life are described in this review. The influence of different transcription factors and microRNAs on the expression of cell cycle proteins is demonstrated. This review also deals major pathways (PI3K/AKT, Wnt/β-catenin, and Hippo-YAP) associated with cardiomyocyte cell cycle progression. Furthermore, the postnatal alterations in structure and cellular events responsible for the loss of cell cycle activity are also illustrated.

Entities:  

Keywords:  Cardiomyocytes; Cell cycle; Cyclins; MicroRNAs; Signaling pathways; Transcription factors

Mesh:

Substances:

Year:  2016        PMID: 27695872     DOI: 10.1007/s00018-016-2375-y

Source DB:  PubMed          Journal:  Cell Mol Life Sci        ISSN: 1420-682X            Impact factor:   9.261


  102 in total

1.  MEF2D deficiency in neonatal cardiomyocytes triggers cell cycle re-entry and programmed cell death in vitro.

Authors:  Nelsa L Estrella; Amanda L Clark; Cody A Desjardins; Sarah E Nocco; Francisco J Naya
Journal:  J Biol Chem       Date:  2015-08-20       Impact factor: 5.157

2.  Dynamic changes in the cardiac methylome during postnatal development.

Authors:  Choon Boon Sim; Mark Ziemann; Antony Kaspi; K N Harikrishnan; Jenny Ooi; Ishant Khurana; Lisa Chang; James E Hudson; Assam El-Osta; Enzo R Porrello
Journal:  FASEB J       Date:  2014-12-09       Impact factor: 5.191

3.  Epigenetic modification at Notch responsive promoters blunts efficacy of inducing notch pathway reactivation after myocardial infarction.

Authors:  Giulia Felician; Chiara Collesi; Marina Lusic; Valentina Martinelli; Matteo Dal Ferro; Lorena Zentilin; Serena Zacchigna; Mauro Giacca
Journal:  Circ Res       Date:  2014-08-11       Impact factor: 17.367

Review 4.  Myocyte proliferation in the developing heart.

Authors:  David Sedmera; Robert P Thompson
Journal:  Dev Dyn       Date:  2011-05-02       Impact factor: 3.780

5.  [Correlation between the level of polyploidy and hypertrophy and degree of human atrial cardiomyocyte damage in certain congenital and acquired heart pathologies].

Authors:  I L Erokhina; G V Selivanova; T D Vlasova; O I Emel'ianova
Journal:  Tsitologiia       Date:  1997

6.  Overlapping roles of pocket proteins in the myocardium are unmasked by germ line deletion of p130 plus heart-specific deletion of Rb.

Authors:  W R MacLellan; A Garcia; H Oh; P Frenkel; M C Jordan; K P Roos; M D Schneider
Journal:  Mol Cell Biol       Date:  2005-03       Impact factor: 4.272

7.  Cyclin A2 induces cardiac regeneration after myocardial infarction through cytokinesis of adult cardiomyocytes.

Authors:  Scott D Shapiro; Amaresh K Ranjan; Yoshiaki Kawase; Richard K Cheng; Rina J Kara; Romit Bhattacharya; Gabriela Guzman-Martinez; Javier Sanz; Mario J Garcia; Hina W Chaudhry
Journal:  Sci Transl Med       Date:  2014-02-19       Impact factor: 17.956

8.  Cardiomyocyte proliferation contributes to heart growth in young humans.

Authors:  Mariya Mollova; Kevin Bersell; Stuart Walsh; Jainy Savla; Lala Tanmoy Das; Shin-Young Park; Leslie E Silberstein; Cristobal G Dos Remedios; Dionne Graham; Steven Colan; Bernhard Kühn
Journal:  Proc Natl Acad Sci U S A       Date:  2013-01-09       Impact factor: 11.205

9.  Cell cycle regulators during human atrial development.

Authors:  W H Kim; C U Joo; J H Ku; C H Ryu; K N Koh; G Y Koh; J K Ko
Journal:  Korean J Intern Med       Date:  1998-07       Impact factor: 2.884

10.  Attenuation of microRNA-16 derepresses the cyclins D1, D2 and E1 to provoke cardiomyocyte hypertrophy.

Authors:  Shuai Huang; Xiao Zou; Jie-Ning Zhu; Yong-Heng Fu; Qiu-Xiong Lin; Ye-You Liang; Chun-Yu Deng; Su-Juan Kuang; Meng-Zhen Zhang; Yu-Lin Liao; Xi-Long Zheng; Xi-Yong Yu; Zhi-Xin Shan
Journal:  J Cell Mol Med       Date:  2015-01-13       Impact factor: 5.310

View more
  27 in total

Review 1.  Mechanisms Underlying Cardiomyocyte Development: Can We Exploit Them to Regenerate the Heart?

Authors:  Gabriel Maldonado-Velez; Anthony B Firulli
Journal:  Curr Cardiol Rep       Date:  2021-06-03       Impact factor: 2.931

Review 2.  Adult Cardiomyocyte Cell Cycle Detour: Off-ramp to Quiescent Destinations.

Authors:  Kathleen M Broughton; Mark A Sussman
Journal:  Trends Endocrinol Metab       Date:  2019-06-28       Impact factor: 12.015

3.  Protective Role of lncRNA TTN-AS1 in Sepsis-Induced Myocardial Injury Via miR-29a/E2F2 Axis.

Authors:  Xinghua Pei; Yanhong Wu; Haiming Yu; Yuji Li; Xu Zhou; Yanjun Lei; Wu Lu
Journal:  Cardiovasc Drugs Ther       Date:  2021-09-14       Impact factor: 3.727

4.  Meta-analysis of Transcriptomic Data Reveals Pathophysiological Modules Involved with Atrial Fibrillation.

Authors:  Rodrigo Haas Bueno; Mariana Recamonde-Mendoza
Journal:  Mol Diagn Ther       Date:  2020-10-23       Impact factor: 4.074

Review 5.  Noncoding RNA and Cardiomyocyte Proliferation.

Authors:  Shuang Qu; Chunyu Zeng; Wei Eric Wang
Journal:  Stem Cells Int       Date:  2017-10-31       Impact factor: 5.443

Review 6.  Wnt/β-catenin pathway in arrhythmogenic cardiomyopathy.

Authors:  Alessandra Lorenzon; Martina Calore; Giulia Poloni; Leon J De Windt; Paola Braghetta; Alessandra Rampazzo
Journal:  Oncotarget       Date:  2017-04-27

Review 7.  Targeting the forkhead box protein P1 pathway as a novel therapeutic approach for cardiovascular diseases.

Authors:  Xin-Ming Liu; Sheng-Li Du; Ran Miao; Le-Feng Wang; Jiu-Chang Zhong
Journal:  Heart Fail Rev       Date:  2022-01       Impact factor: 4.214

8.  The microRNAs miR-200b-3p and miR-429-5p target the LIMK1/CFL1 pathway to inhibit growth and motility of breast cancer cells.

Authors:  Dengfeng Li; Hong Wang; Hongming Song; Hui Xu; Bingkun Zhao; Chenyang Wu; Jiashu Hu; Tianqi Wu; Dan Xie; Junyong Zhao; Qiang Shen; Lin Fang
Journal:  Oncotarget       Date:  2017-07-12

9.  AGO2 involves the malignant phenotypes and FAK/PI3K/AKT signaling pathway in hypopharyngeal-derived FaDu cells.

Authors:  Yanhui Zhang; Baoxin Wang; Xinwei Chen; Weidong Li; Pin Dong
Journal:  Oncotarget       Date:  2017-05-22

10.  BMP and Notch Signaling Pathways differentially regulate Cardiomyocyte Proliferation during Ventricle Regeneration.

Authors:  Wenyuan Wang; Ye-Fan Hu; Meijun Pang; Nannan Chang; Chunxiao Yu; Qi Li; Jing-Wei Xiong; Yuanyuan Peng; Ruilin Zhang
Journal:  Int J Biol Sci       Date:  2021-05-27       Impact factor: 6.580

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.